B Kasper, T Moehler, K Neben, A D Ho, H Goldschmidt. Show Affiliations »
Abstract
Entities: Chemical Disease Species
Mesh： See more » AgedAntineoplastic Combined Chemotherapy Protocols/adverse effectsAntineoplastic Combined Chemotherapy Protocols/therapeutic useDisease ProgressionFemaleHumansInterferon alpha-2Interferon-alpha/administration & dosageInterferon-alpha/adverse effectsMaleMiddle AgedMultiple Myeloma/drug therapyMultiple Myeloma/mortalityMultiple Myeloma/pathologyPolyethylene GlycolsRecombinant ProteinsSurvival AnalysisThalidomide/administration & dosageThalidomide/adverse effects
Substances： See more » Interferon alpha-2Interferon-alphaRecombinant ProteinsPolyethylene GlycolsThalidomidepeginterferon alfa-2bpeginterferon alfa-2a
Year: 2004 PMID： 14679142 DOI： 10.1093/annonc/mdh030
Source DB: PubMed Journal: Ann Oncol ISSN： 0923-7534 Impact factor: 32.976